» Articles » PMID: 35612812

Psychological Stress, Emotions, and Quality of Life in Men and Women with Congenital Adrenal Hyperplasia

Overview
Publisher Springer
Specialty Endocrinology
Date 2022 May 25
PMID 35612812
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The aim was to assess perceived psychological stress, emotional state, and quality of life (QoL) in men and women with congenital adrenal hyperplasia (CAH) in comparison to age- and sex-matched control individuals.

Methods: Participants: 26 patients with CAH (11 men, 15 women, age 14-48 years) and 26 age- and sex-matched control individuals without CAH. Psychological assessment: Perceived Stress Scale, Profile of Mood States2, and WHO Brief Quality of Life Questionnaire.

Results: There were no significant differences in perceived stress, emotional state and QoL scores between men with CAH and control men. Perceived distress (median 14.0 score vs. 10.0 score, p = 0.020), tension-anxiety (median 9.0 score vs. 3.5 score, p = 0.026), depression-dejection (median 12.0 score vs. 5.0 score, p = 0.040), fatigue-inertia (median 13.0 score vs. 7.5 score, p = 0.007) were higher and environmental domain of QoL (median 16.0 score vs. 17.0 score, p = 0.001) was lower in women with CAH than in control women.

Conclusion: Women with congenital adrenal hyperplasia have higher perceived distress, tension-anxiety, depression dejection, fatigue-inertia, and worse environmental aspect of quality of life than age-matched control women, while perceived psychological stress, emotional state and quality of life in men with congenital adrenal hyperplasia do not differ from that of age-matched control men.

Citing Articles

Severe Hyperandrogenism in 46,XX Congenital Adrenal Hyperplasia: Molecular Physiopathology, Late Diagnoses, and Personalized Management.

Cera G, Corsello A, Novizio R, Di Donna V, Locantore P, Paragliola R Int J Mol Sci. 2024; 25(21).

PMID: 39519330 PMC: 11545884. DOI: 10.3390/ijms252111779.

References
1.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

2.
Navardauskaite R, Baneviciute K, Songailiene J, Grigalioniene K, cereskevicius D, Sukys M . Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia. Medicina (Kaunas). 2021; 57(10). PMC: 8540623. DOI: 10.3390/medicina57101035. View

3.
Nordenstrom A, Falhammar H . MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency. Eur J Endocrinol. 2018; 180(3):R127-R145. DOI: 10.1530/EJE-18-0712. View

4.
Zainuddin A, Grover S, Shamsuddin K, Mahdy Z . Research on quality of life in female patients with congenital adrenal hyperplasia and issues in developing nations. J Pediatr Adolesc Gynecol. 2013; 26(6):296-304. DOI: 10.1016/j.jpag.2012.08.004. View

5.
Carroll L, Graff C, Wicks M, Thomas A . Living with an invisible illness: a qualitative study exploring the lived experiences of female children with congenital adrenal hyperplasia. Qual Life Res. 2019; 29(3):673-681. DOI: 10.1007/s11136-019-02350-2. View